Abstract
Our understanding of liver cancer has rapidly progressed through analysis of genomic/epigenomic/proteomic data from tumors. To take advantage of the advancement, it will be necessary to develop systematic approaches that can uncover potential biomarkers reflecting genetic alterations, prognosis, or response to treatments. In this chapter, updated results and future perspectives of liver cancer toward personalized medicine using genomics, bioinformatics, and systems biology approaches were summarized.
| Original language | English |
|---|---|
| Title of host publication | Cancer Genetics and Genomics for Personalized Medicine |
| Publisher | Pan Stanford Publishing Pte. Ltd. |
| Pages | 39-51 |
| Number of pages | 13 |
| ISBN (Electronic) | 9789814669887 |
| ISBN (Print) | 9789814669870 |
| DOIs | |
| Publication status | Published - 1 Jan 2017 |
Bibliographical note
Publisher Copyright:© 2017 Pan Stanford Publishing Pte. Ltd.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Genome-based personalized medicine in liver cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver